Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$146,330
New position
Shares Held
122
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4,462
of 4,605 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ANTIPODES PARTNERS Ltd holds $183,532,568 across 5 Drug Manufacturers - General names. LLY ranks #5 (0.1% of the industry book) .
All Filings in LLY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $146,330 | 122 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||